These studies examine the impact of altered FLAP expression on inflammatory signaling, immune cell regulation and lipid mediator synthesis in various disease contexts, including glioma, osteosarcoma and stress-induced organ injury [97–99]. Here, ALOX5AP is linked to central nervous system cancer.